The new 2012 German recommendations for treating rheumatoid arthritis
Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Wollenhaupt, J. [verfasserIn] Albrecht, K. [verfasserIn] Krüger, K. [verfasserIn] Müller-Ladner, U. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Zeitschrift für Rheumatologie - Steinkopff-Verlag, 1998, 72(2013), 1 vom: Feb., Seite 6-9 |
|---|---|
| Übergeordnetes Werk: |
volume:72 ; year:2013 ; number:1 ; month:02 ; pages:6-9 |
| Links: |
|---|
| DOI / URN: |
10.1007/s00393-012-1093-6 |
|---|
| Katalog-ID: |
SPR004829654 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR004829654 | ||
| 003 | DE-627 | ||
| 005 | 20230519174944.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201001s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00393-012-1093-6 |2 doi | |
| 035 | |a (DE-627)SPR004829654 | ||
| 035 | |a (SPR)s00393-012-1093-6-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wollenhaupt, J. |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The new 2012 German recommendations for treating rheumatoid arthritis |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. | ||
| 650 | 4 | |a Rheumatoid arthritis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Therapy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Guideline |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Recommendation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Biologics |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a DMARDS |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Albrecht, K. |e verfasserin |4 aut | |
| 700 | 1 | |a Krüger, K. |e verfasserin |4 aut | |
| 700 | 1 | |a Müller-Ladner, U. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zeitschrift für Rheumatologie |d Steinkopff-Verlag, 1998 |g 72(2013), 1 vom: Feb., Seite 6-9 |w (DE-627)SPR004818482 |7 nnns |
| 773 | 1 | 8 | |g volume:72 |g year:2013 |g number:1 |g month:02 |g pages:6-9 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00393-012-1093-6 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 72 |j 2013 |e 1 |c 02 |h 6-9 | ||
| author_variant |
j w jw k a ka k k kk u m l uml |
|---|---|
| matchkey_str |
wollenhauptjalbrechtkkrgerkmllerladneru:2013----:hnw02emneomnainfrraigh |
| hierarchy_sort_str |
2013 |
| publishDate |
2013 |
| allfields |
10.1007/s00393-012-1093-6 doi (DE-627)SPR004829654 (SPR)s00393-012-1093-6-e DE-627 ger DE-627 rakwb eng Wollenhaupt, J. verfasserin aut The new 2012 German recommendations for treating rheumatoid arthritis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. Rheumatoid arthritis (dpeaa)DE-He213 Therapy (dpeaa)DE-He213 Guideline (dpeaa)DE-He213 Recommendation (dpeaa)DE-He213 Biologics (dpeaa)DE-He213 DMARDS (dpeaa)DE-He213 Albrecht, K. verfasserin aut Krüger, K. verfasserin aut Müller-Ladner, U. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 72(2013), 1 vom: Feb., Seite 6-9 (DE-627)SPR004818482 nnns volume:72 year:2013 number:1 month:02 pages:6-9 https://dx.doi.org/10.1007/s00393-012-1093-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 72 2013 1 02 6-9 |
| spelling |
10.1007/s00393-012-1093-6 doi (DE-627)SPR004829654 (SPR)s00393-012-1093-6-e DE-627 ger DE-627 rakwb eng Wollenhaupt, J. verfasserin aut The new 2012 German recommendations for treating rheumatoid arthritis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. Rheumatoid arthritis (dpeaa)DE-He213 Therapy (dpeaa)DE-He213 Guideline (dpeaa)DE-He213 Recommendation (dpeaa)DE-He213 Biologics (dpeaa)DE-He213 DMARDS (dpeaa)DE-He213 Albrecht, K. verfasserin aut Krüger, K. verfasserin aut Müller-Ladner, U. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 72(2013), 1 vom: Feb., Seite 6-9 (DE-627)SPR004818482 nnns volume:72 year:2013 number:1 month:02 pages:6-9 https://dx.doi.org/10.1007/s00393-012-1093-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 72 2013 1 02 6-9 |
| allfields_unstemmed |
10.1007/s00393-012-1093-6 doi (DE-627)SPR004829654 (SPR)s00393-012-1093-6-e DE-627 ger DE-627 rakwb eng Wollenhaupt, J. verfasserin aut The new 2012 German recommendations for treating rheumatoid arthritis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. Rheumatoid arthritis (dpeaa)DE-He213 Therapy (dpeaa)DE-He213 Guideline (dpeaa)DE-He213 Recommendation (dpeaa)DE-He213 Biologics (dpeaa)DE-He213 DMARDS (dpeaa)DE-He213 Albrecht, K. verfasserin aut Krüger, K. verfasserin aut Müller-Ladner, U. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 72(2013), 1 vom: Feb., Seite 6-9 (DE-627)SPR004818482 nnns volume:72 year:2013 number:1 month:02 pages:6-9 https://dx.doi.org/10.1007/s00393-012-1093-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 72 2013 1 02 6-9 |
| allfieldsGer |
10.1007/s00393-012-1093-6 doi (DE-627)SPR004829654 (SPR)s00393-012-1093-6-e DE-627 ger DE-627 rakwb eng Wollenhaupt, J. verfasserin aut The new 2012 German recommendations for treating rheumatoid arthritis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. Rheumatoid arthritis (dpeaa)DE-He213 Therapy (dpeaa)DE-He213 Guideline (dpeaa)DE-He213 Recommendation (dpeaa)DE-He213 Biologics (dpeaa)DE-He213 DMARDS (dpeaa)DE-He213 Albrecht, K. verfasserin aut Krüger, K. verfasserin aut Müller-Ladner, U. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 72(2013), 1 vom: Feb., Seite 6-9 (DE-627)SPR004818482 nnns volume:72 year:2013 number:1 month:02 pages:6-9 https://dx.doi.org/10.1007/s00393-012-1093-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 72 2013 1 02 6-9 |
| allfieldsSound |
10.1007/s00393-012-1093-6 doi (DE-627)SPR004829654 (SPR)s00393-012-1093-6-e DE-627 ger DE-627 rakwb eng Wollenhaupt, J. verfasserin aut The new 2012 German recommendations for treating rheumatoid arthritis 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. Rheumatoid arthritis (dpeaa)DE-He213 Therapy (dpeaa)DE-He213 Guideline (dpeaa)DE-He213 Recommendation (dpeaa)DE-He213 Biologics (dpeaa)DE-He213 DMARDS (dpeaa)DE-He213 Albrecht, K. verfasserin aut Krüger, K. verfasserin aut Müller-Ladner, U. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 72(2013), 1 vom: Feb., Seite 6-9 (DE-627)SPR004818482 nnns volume:72 year:2013 number:1 month:02 pages:6-9 https://dx.doi.org/10.1007/s00393-012-1093-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 72 2013 1 02 6-9 |
| language |
English |
| source |
Enthalten in Zeitschrift für Rheumatologie 72(2013), 1 vom: Feb., Seite 6-9 volume:72 year:2013 number:1 month:02 pages:6-9 |
| sourceStr |
Enthalten in Zeitschrift für Rheumatologie 72(2013), 1 vom: Feb., Seite 6-9 volume:72 year:2013 number:1 month:02 pages:6-9 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Rheumatoid arthritis Therapy Guideline Recommendation Biologics DMARDS |
| isfreeaccess_bool |
true |
| container_title |
Zeitschrift für Rheumatologie |
| authorswithroles_txt_mv |
Wollenhaupt, J. @@aut@@ Albrecht, K. @@aut@@ Krüger, K. @@aut@@ Müller-Ladner, U. @@aut@@ |
| publishDateDaySort_date |
2013-02-01T00:00:00Z |
| hierarchy_top_id |
SPR004818482 |
| id |
SPR004829654 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR004829654</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519174944.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201001s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00393-012-1093-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR004829654</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00393-012-1093-6-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wollenhaupt, J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The new 2012 German recommendations for treating rheumatoid arthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatoid arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Guideline</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recommendation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biologics</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DMARDS</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Albrecht, K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Krüger, K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller-Ladner, U.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Zeitschrift für Rheumatologie</subfield><subfield code="d">Steinkopff-Verlag, 1998</subfield><subfield code="g">72(2013), 1 vom: Feb., Seite 6-9</subfield><subfield code="w">(DE-627)SPR004818482</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:72</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:6-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00393-012-1093-6</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">72</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">6-9</subfield></datafield></record></collection>
|
| author |
Wollenhaupt, J. |
| spellingShingle |
Wollenhaupt, J. misc Rheumatoid arthritis misc Therapy misc Guideline misc Recommendation misc Biologics misc DMARDS The new 2012 German recommendations for treating rheumatoid arthritis |
| authorStr |
Wollenhaupt, J. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR004818482 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
The new 2012 German recommendations for treating rheumatoid arthritis Rheumatoid arthritis (dpeaa)DE-He213 Therapy (dpeaa)DE-He213 Guideline (dpeaa)DE-He213 Recommendation (dpeaa)DE-He213 Biologics (dpeaa)DE-He213 DMARDS (dpeaa)DE-He213 |
| topic |
misc Rheumatoid arthritis misc Therapy misc Guideline misc Recommendation misc Biologics misc DMARDS |
| topic_unstemmed |
misc Rheumatoid arthritis misc Therapy misc Guideline misc Recommendation misc Biologics misc DMARDS |
| topic_browse |
misc Rheumatoid arthritis misc Therapy misc Guideline misc Recommendation misc Biologics misc DMARDS |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Zeitschrift für Rheumatologie |
| hierarchy_parent_id |
SPR004818482 |
| hierarchy_top_title |
Zeitschrift für Rheumatologie |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)SPR004818482 |
| title |
The new 2012 German recommendations for treating rheumatoid arthritis |
| ctrlnum |
(DE-627)SPR004829654 (SPR)s00393-012-1093-6-e |
| title_full |
The new 2012 German recommendations for treating rheumatoid arthritis |
| author_sort |
Wollenhaupt, J. |
| journal |
Zeitschrift für Rheumatologie |
| journalStr |
Zeitschrift für Rheumatologie |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
txt |
| container_start_page |
6 |
| author_browse |
Wollenhaupt, J. Albrecht, K. Krüger, K. Müller-Ladner, U. |
| container_volume |
72 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Wollenhaupt, J. |
| doi_str_mv |
10.1007/s00393-012-1093-6 |
| author2-role |
verfasserin |
| title_sort |
new 2012 german recommendations for treating rheumatoid arthritis |
| title_auth |
The new 2012 German recommendations for treating rheumatoid arthritis |
| abstract |
Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. |
| abstractGer |
Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. |
| abstract_unstemmed |
Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
The new 2012 German recommendations for treating rheumatoid arthritis |
| url |
https://dx.doi.org/10.1007/s00393-012-1093-6 |
| remote_bool |
true |
| author2 |
Albrecht, K. Krüger, K. Müller-Ladner, U. |
| author2Str |
Albrecht, K. Krüger, K. Müller-Ladner, U. |
| ppnlink |
SPR004818482 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s00393-012-1093-6 |
| up_date |
2024-07-04T02:44:20.076Z |
| _version_ |
1803614746132348928 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR004829654</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519174944.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201001s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00393-012-1093-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR004829654</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00393-012-1093-6-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wollenhaupt, J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The new 2012 German recommendations for treating rheumatoid arthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The German Society for Rheumatology recently published guidelines for the sequential therapy of rheumatoid arthritis (RA). These recommendations were developed as a transition from the 2010 EULAR (EUropean League Against Rheumatism) recommendations to the national clinical practice and are based on an updated systematic literature research and expert discussion. While most EULAR recommendations have remained unchanged, some were modified based on new evidence from randomized, controlled trials, current clinical practice, or national drug approval status. The guidelines also include a treatment algorithm for sequential therapy of RA with disease-modifying agents including biologics.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatoid arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Guideline</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recommendation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biologics</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DMARDS</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Albrecht, K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Krüger, K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller-Ladner, U.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Zeitschrift für Rheumatologie</subfield><subfield code="d">Steinkopff-Verlag, 1998</subfield><subfield code="g">72(2013), 1 vom: Feb., Seite 6-9</subfield><subfield code="w">(DE-627)SPR004818482</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:72</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:6-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00393-012-1093-6</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">72</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">6-9</subfield></datafield></record></collection>
|
| score |
7.4021015 |